• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[与严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染(2019冠状病毒病)相关的急性脑血管意外]

[Acute cerebrovascular accidents associated with SARS-CoV-2 coronavirus infection (COVID-19)].

作者信息

Putilina M V, Vechorko V I, Grishin D V, Sidelnikova L V

机构信息

Pirogov Russian National Research Medical University, Moscow, Russia.

Filatov Clinical Hospital, Moscow, Russia.

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(12):109-117. doi: 10.17116/jnevro2020120121109.

DOI:10.17116/jnevro2020120121109
PMID:33459550
Abstract

Acute cerebrovascular accidents (ACVIs) associated with COVID-19 coronavirus infection are one of the most talked about problems in the medical community. To date, the true incidence of stroke in patients with COVID-19 remains unclear. So far, the published literature has been limited to case reports, case series, and observational cohort studies. The article analyzes possible risk factors, especially the age of patients, pathogenetic and clinical correlations of ACVA and SARS-CoV-2 (COVID-19). A clinical case of an 82-year-old patient with ischemic stroke and COVID-19 infection is described.

摘要

与新型冠状病毒肺炎(COVID-19)冠状病毒感染相关的急性脑血管意外(ACVIs)是医学界讨论最多的问题之一。迄今为止,COVID-19患者中风的真实发病率仍不清楚。到目前为止,已发表的文献仅限于病例报告、病例系列和观察性队列研究。本文分析了可能的危险因素,特别是患者年龄、急性脑血管意外(ACVA)与严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即COVID-19)的发病机制及临床相关性。文中描述了一名82岁缺血性中风合并COVID-19感染患者的临床病例。

相似文献

1
[Acute cerebrovascular accidents associated with SARS-CoV-2 coronavirus infection (COVID-19)].[与严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染(2019冠状病毒病)相关的急性脑血管意外]
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(12):109-117. doi: 10.17116/jnevro2020120121109.
2
Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.COVID-19 感染患者的恶性大脑缺血:病例回顾与组织病理学发现。
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105231. doi: 10.1016/j.jstrokecerebrovasdis.2020.105231. Epub 2020 Aug 5.
3
Unprotected stroke management in an undiagnosed case of Severe Acute Respiratory Syndrome Coronavirus 2 infection.未确诊的严重急性呼吸综合征冠状病毒2感染病例中的无保护卒中管理
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):104981. doi: 10.1016/j.jstrokecerebrovasdis.2020.104981. Epub 2020 May 23.
4
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.COVID-19、肥大细胞、细胞因子风暴、心理压力和神经炎症。
Neuroscientist. 2020 Oct-Dec;26(5-6):402-414. doi: 10.1177/1073858420941476. Epub 2020 Jul 18.
5
Cerebrovascular Accident and SARS-CoV-19 (COVID-19): A Systematic Review.脑血管意外与严重急性呼吸系统综合征冠状病毒 1 型(COVID-19):系统评价。
Eur Neurol. 2021;84(6):418-425. doi: 10.1159/000517403. Epub 2021 Aug 5.
6
Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemic.2019年冠状病毒病大流行期间对超急性卒中患者进行严重急性呼吸综合征冠状病毒2的通用实验室检测。
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105061. doi: 10.1016/j.jstrokecerebrovasdis.2020.105061. Epub 2020 Jun 20.
7
The impact of COVID-19 on ischemic stroke.新冠疫情对缺血性脑卒中的影响。
Diagn Pathol. 2020 Jun 29;15(1):78. doi: 10.1186/s13000-020-00994-0.
8
Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature.脑血管病与 2019 年冠状病毒病(COVID-19)患者的疾病严重程度增加相关:已发表文献的汇总分析。
Int J Stroke. 2020 Jun;15(4):385-389. doi: 10.1177/1747493020921664. Epub 2020 Apr 20.
9
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者:体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
10
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染:英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.

引用本文的文献

1
Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.新冠后综合征患病率的测定及药物皮质素治疗新冠后综合征患者神经障碍的有效性评估。CORTEX多中心临床与流行病学观察项目的结果
Neurosci Behav Physiol. 2022;52(6):836-841. doi: 10.1007/s11055-022-01307-2. Epub 2022 Oct 26.